<link rel="stylesheet" href="styles.cf390c6bfbe7555f.css">

Benefits and risks of antiretroviral therapy for perinatal HIV prevention.

Abstract

Abstract available in pdf.

Description

CAPRISA, 2016.

Keywords

Citation

Fowler, M.G., Qin, M., Fiscus, S.A., Currier, J.S., Flynn, P.M., Chipato, T., McIntyre, J., Gnanashanmugam, D., Siberry, G.K., Coletti, A.S., Taha, T.E., Klingman, K.L., Martinson, F.E., Owor, M., Violari, A., Moodley, D., Theron, G.B., Bhosale, R., Bobat, R., Chi, B.H., Strehlau, R., Mlay,P., Loftis, A.J., Browning, R., Fenton, T., Purdue, L., Basar, M., Shapiro, D.E. and Mofenson, L.M. 2016. Benefits and risks of antiretroviral therapy for perinatal HIV prevention. New England Journal of Medicine 375(18), 1726-1737.

Endorsement

Review

Supplemented By

Referenced By